Show simple item record

dc.contributor.authorCrundwell, Malcolm
dc.date.accessioned2020-05-12T13:43:24Z
dc.date.available2020-05-12T13:43:24Z
dc.date.issued2020-02
dc.identifier.citationHuddart RA [et al]. Patient-reported Quality of Life outcomes in patients treated for muscle-invasive bladder cancer with radiotherapy ± chemotherapy in the BC2001 Phase III Randomised Controlled Trial. European Urology. 2020 Feb;77(2):260-268en_US
dc.identifier.pmid31843338
dc.identifier.doi10.1016/j.eururo.2019.11.001
dc.identifier.urihttps://rde.dspace-express.com/handle/11287/621272
dc.description.abstractBC2001, the largest randomised trial of bladder-sparing treatment for muscle-invasive bladder cancer, demonstrated improvement of local control and bladder cancer-specific survival from the addition of concomitant 5-fluorouracil and mitomycin C to radiotherapy.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31843338/en_US
dc.rightsThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)en_US
dc.subjectWessex Classification Subject Headings::Urologyen_US
dc.titlePatient-reported Quality of Life outcomes in patients treated for muscle-invasive bladder cancer with radiotherapy ± chemotherapy in the BC2001 Phase III Randomised Controlled Trialen_US
dc.typeJournal Articleen_US
dc.typeRandomized Controlled Trialen_US
dc.identifier.journalEuropean Urologyen_US
dc.identifier.pmcidPMC6983941
dc.description.noteThis article is available via Open Access. Click on the Publisher URL to access the full-text.en_US
dc.type.versionPublisheden_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record